Page last updated: 2024-10-28

hydrochlorothiazide and Capillary Leak Syndrome

hydrochlorothiazide has been researched along with Capillary Leak Syndrome in 1 studies

Hydrochlorothiazide: A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
hydrochlorothiazide : A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure.

Capillary Leak Syndrome: A condition characterized by recurring episodes of fluid leaking from capillaries into extra-vascular compartments causing hematocrit to rise precipitously. If not treated, generalized vascular leak can lead to generalized EDEMA; SHOCK; cardiovascular collapse; and MULTIPLE ORGAN FAILURE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Vadas, P1

Other Studies

1 other study available for hydrochlorothiazide and Capillary Leak Syndrome

ArticleYear
Hydrochlorothiazide-induced systemic capillary leak.
    The American journal of emergency medicine, 2020, Volume: 38, Issue:6

    Topics: Capillary Leak Syndrome; Heart Arrest; Humans; Hydrochlorothiazide; Male; Middle Aged

2020